The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Barton Haynes Georgia D. Tomaras Richard A Koup Raphael Gottardo Merlin L Robb Peter B Gilbert Supachai Rerks-Ngarm Jaranit Kaewkungwal Nelson Michael James Tartaglia Sorachai Nitayaphan Craig A Magaret MOPH TAVEG Collaboration Sirinan Madnote John R. Mascola Jerome H Kim Mangala Rao David C. Montefiori Punnee Pitisuttithum Jeffrey R Currier Timothy Cardozo Susan Zolla-Pazner Nicos Karasavvas Erik A Billings Viseth Ngauy Kelli Greene Sanjay Gurunathan Bette Korber Faruk Sinangil Charla A Andrews |
| Publication date | October 4, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |